Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Chemotherapy for Prevention of Recurrence in Patients With Detectable ctDNA After Surgery in High-Risk Rectal Cancer

NCT07188025 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT07188025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07188025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Chemotherapy for Prevention of Recurrence in Patients With Detectable ctDNA After Surgery in High-Risk Rectal Cancer
Lead sponsor
Erasmus Medical Center
Phase
Phase 3
Overall status
Recruiting
Start date
October 14, 2025
Completion date
October 31, 2035
Enrollment
103 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer